MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions
MAPK通路改变与ROS1融合驱动的肺癌患者的生存率低相关,并导致治疗耐药性
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-3321
Sato, Hiroki; Schoenfeld, Adam J; Siau, Evan; Lu, Yue Christine; Tai, Huichun; Suzawa, Ken; Kubota, Daisuke; Lui, Allan J W; Qeriqi, Besnik; Mattar, Marissa; Offin, Michael; Sakaguchi, Masakiyo; Toyooka, Shinichi; Drilon, Alexander; Rosen, Neal X; Kris, Mark G; Solit, David; De Stanchina, Elisa; Davare, Monika A; Riely, Gregory J; Ladanyi, Marc; Somwar, Romel